A company selling a version of an anti-retroviral drug used in the treatment of people living with HIV/AIDS is breaching the Irish patent for the product, it is claimed.

GlaxoSmithKline, battered by weak US drug sales and a bribery scandal inChina, set out a bold recovery plan yesterday, including an initial public offering of part of its fast-growing HIV and AIDS drugs business.